GSK.L - GlaxoSmithKline plc

GlaxoSmithKline plc

980 Great West Road
Brentford TW8 9GS
United Kingdom
44 20 8047 5000
http://www.gsk.com

Sector: Healthcare
Industry: Drug Manufacturers—General
Full-time employees: 99,437

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Emma N. Walmsley	CEO & Director	3.29M	1.6M	1970
Mr. Iain James Mackay	CFO & Exec. Director	2.36M	N/A	1962
Dr. Hal V. Barron	Chief Scientific Officer, Pres of R&D and Director	6.34M	N/A	1963
Ms. Karenann K. Terrell	Chief Digital & Technology Officer	N/A	N/A	1962
Ms. Sarah Elton-Farr	Head of Investor Relations	N/A	N/A	N/A

Amounts are as of 31 December 2019, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories primarily under the Sensodyne, parodontax, Poligrip, Voltaren, Panadol, Otrivin, and Theraflu brand names. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, pods, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, and malted drinks and foods. It has collaboration agreements with 23andMe; Liquidia Technologies, Inc.; SpringWorks Therapeutics, Inc.; Merck KGaA.; Lyell Immunopharma; CEPI; and Viome, as well as a strategic collaboration agreement with GSK to develop novel adoptive cell therapies targeting multiple cancer indications. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Corporate governance

GlaxoSmithKline plc’s ISS governance QualityScore as of 4 December 2019 is 5. The pillar scores are Audit: 1; Board: 6; Shareholder rights: 1; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.